参考文献

2020-10-22

1: Brett K, Farrah K. Sugammadex for the Reversal of Rocuronium-Induced Neuromuscular Blockade in Surgical Patients: A Review of Clinical Effectiveness [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Aug 21. Available from http://www.ncbi.nlm.nih.gov/books/NBK549465/ PubMed PMID: 31697460.

2: Brett K, Farrah K. Sugammadex for the Reversal of Neuromuscular Blockade in Surgical Patients: A Review of Clinical Effectiveness and Cost-Effectiveness [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Aug 6. Available from http://www.ncbi.nlm.nih.gov/books/NBK549205/ PubMed PMID: 31682387.

3: Honing G, Martini CH, Bom A, van Velzen M, Niesters M, Aarts L, Dahan A, Boon M. Safety of sugammadex for reversal of neuromuscular block. Expert Opin Drug Saf. 2019 Oct;18(10):883-891. doi: 10.1080/14740338.2019.1649393. Epub 2019 Aug 7. Review. PubMed PMID: 31359807.

4: de Boer HD, Carlos RV, Brull SJ. Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction. BMC Anesthesiol. 2018 Nov 6;18(1):159. doi: 10.1186/s12871-018-0605-6. Review. PubMed PMID: 30400850; PubMed Central PMCID: PMC6220468.

5: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK500924/ PubMed PMID: 29999983.

6: Cammu G. Sugammadex: Appropriate Use in the Context of Budgetary Constraints. Curr Anesthesiol Rep. 2018;8(2):178-185. doi: 10.1007/s40140-018-0265-6. Epub 2018 Mar 20. Review. PubMed PMID: 29904285; PubMed Central PMCID: PMC5988778.

7: Bedirli N, Işık B, Bashiri M, Pampal K, Kurtipek Ö. Clinically suspected anaphylaxis induced by sugammadex in a patient with Weaver syndrome undergoing restrictive mammoplasty surgery: A case report with the literature review. Medicine (Baltimore). 2018 Jan;97(3):e9661. doi: 10.1097/MD.0000000000009661. Review. PubMed PMID: 29505006; PubMed Central PMCID: PMC5779775.

8: Carron M, Bertoncello F, Ieppariello G. Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives. Clin Interv Aging. 2017 Dec 22;13:13-24. doi: 10.2147/CIA.S134108. eCollection 2018. Review. PubMed PMID: 29317806; PubMed Central PMCID: PMC5743185.

9: Chandrasekhar K, Jeffers JL. Sugammadex. 2019 Oct 17. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK470263/ PubMed PMID: 29262181.

10: Papathanas MR, Killian A. Sugammadex for Neuromuscular Blockade Reversal. Adv Emerg Nurs J. 2017 Oct/Dec;39(4):248-257. doi: 10.1097/TME.0000000000000170. Review. PubMed PMID: 29095176.

11: Iwasaki H, Renew JR, Kunisawa T, Brull SJ. Preparing for the unexpected: special considerations and complications after sugammadex administration. BMC Anesthesiol. 2017 Oct 17;17(1):140. doi: 10.1186/s12871-017-0429-9. Review. PubMed PMID: 29041919; PubMed Central PMCID: PMC5645926.

12: Hristovska AM, Duch P, Allingstrup M, Afshari A. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database Syst Rev. 2017 Aug 14;8:CD012763. doi: 10.1002/14651858.CD012763. Review. PubMed PMID: 28806470; PubMed Central PMCID: PMC6483345.

13: Carron M, Zarantonello F, Lazzarotto N, Tellaroli P, Ori C. Role of sugammadex in accelerating postoperative discharge: A meta-analysis. J Clin Anesth. 2017 Jun;39:38-44. doi: 10.1016/j.jclinane.2017.03.004. Epub 2017 Mar 23. Review. PubMed PMID: 28494905.

14: Zoremba N, Schälte G, Bruells C, Pühringer FK. [Update on muscle relaxation : What comes after succinylcholine, rocuronium and sugammadex?]. Anaesthesist. 2017 May;66(5):353-359. doi: 10.1007/s00101-017-0289-1. Review. German. PubMed PMID: 28289767.

15: Hussar DA, Cheeseman RS 2nd. Lifitegrast, Bezlotoxumab, and Sugammadex sodium. J Am Pharm Assoc (2003). 2017 Mar - Apr;57(2):284-287. doi: 10.1016/j.japh.2017.02.004. Review. PubMed PMID: 28285777.

16: Carron M, Zarantonello F, Tellaroli P, Ori C. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials. J Clin Anesth. 2016 Dec;35:1-12. doi: 10.1016/j.jclinane.2016.06.018. Epub 2016 Aug 4. Review. PubMed PMID: 27871504.

17: Tobias JD. Current evidence for the use of sugammadex in children. Paediatr Anaesth. 2017 Feb;27(2):118-125. doi: 10.1111/pan.13050. Epub 2016 Nov 17. Review. Erratum in: Paediatr Anaesth. 2017 Jul;27(7):781. PubMed PMID: 27859917.

18: Schaller SJ, Lewald H. Clinical pharmacology and efficacy of sugammadex in the reversal of neuromuscular blockade. Expert Opin Drug Metab Toxicol. 2016 Sep;12(9):1097-108. doi: 10.1080/17425255.2016.1215426. Epub 2016 Aug 3. Review. PubMed PMID: 27463265.

19: Carlos RV, Torres ML, de Boer HD. Rocuronium and sugammadex in a 3 days old neonate for draining an ovarian cyst. Neuromuscular management and review of the literature. Braz J Anesthesiol. 2016 Jul-Aug;66(4):430-2. doi: 10.1016/j.bjane.2015.01.004. Epub 2015 Sep 26. Review. PubMed PMID: 27343797.

20: Sugammadex for the Reversal of Neuromuscular Blockade in Adult Patients: A Review of Clinical Effectiveness and Cost-Effectiveness [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 May 26. Available from http://www.ncbi.nlm.nih.gov/books/NBK368313/ PubMed PMID: 27336121.